Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05723822 · ClinicalTrials.gov registry record · NA
Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments
A NA study, sponsored by RxFunction.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05723822 is a NA study that has completed, run by RxFunction. The registered enrollment target is 12 participants.
The verdict
NCT05723822, a NA study, has completed, sponsored by RxFunction.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary aim of this pilot study is to investigate the effect of Walkasins, a wearable lower-limb sensory prosthesis, on the gait speed and balance function of participants with mild cognitive impairment as measured by the Saint Louis University Mental Status (SLUMS) Examination.
Interventions
- DEVICE Walkasins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-02-16 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05723822
The ClinicalTrials.gov registry entry for NCT05723822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RxFunction, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Walkasins is the first listed.
NCT05723822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05723822 about?
NCT05723822 is a clinical study titled "Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments". The primary aim of this pilot study is to investigate the effect of Walkasins, a wearable lower-limb sensory prosthesis, on the gait speed and balance function of participants with mild cognitive impairment as measured by the Saint Louis University Mental Status (SLUMS) Examination.
What is the current status of trial NCT05723822?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2023-02-16. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT05723822?
The interventions under investigation include: Walkasins (DEVICE).
Who is sponsoring clinical trial NCT05723822?
This trial is sponsored by RxFunction, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.